| |
 |
|
Class Information
Number: 424/188.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same > Disclosed amino acid sequence derived from virus > Retroviridae (e.g., feline leukemia, etc.) > Immunodeficiency virus (e.g., hiv, etc.)
Description: Subject matter wherein the virus is one that is associated with an immunodeficiency syndrome such as AIDS in humans or an AIDS-related syndrome in animals.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7618642 |
Expression cassettes encoding modified human immunodeficiency virus type 1 subtype C envelope glycoproteins |
Nov. 17, 2009 |
| 7611712 |
Immunogenic compositions capable of eliciting Th1 immune responses comprising an HIV-1 MA myristate binding site polypeptide |
Nov. 3, 2009 |
| 7612168 |
Modified HIV peptides, antigens, compositions, immunoassay kit and a method of detecting antibodies induced by HIV |
Nov. 3, 2009 |
| 7608268 |
Ferritin fusion proteins for use in vaccines and other applications |
Oct. 27, 2009 |
| 7608273 |
Recombinant lentivirus encoding modified GP 120 signal sequences |
Oct. 27, 2009 |
| 7608271 |
Modified human immunodeficiency virus anti-fusogenic GP41 peptides comprising a maleimide-containing group |
Oct. 27, 2009 |
| 7588764 |
Compositions comprising human immunodeficiency virus Tat adsorbed to the surface of anionic nanoparticles |
Sep. 15, 2009 |
| 7582301 |
Long-lasting antiviral fusion inhibitor peptide conjugates comprising albumin and human immunodeficiency virus (HIV) peptides |
Sep. 1, 2009 |
| 7575750 |
Human immunodeficiency virus (HIV) gp41 peptide derivatives with enhanced solubility and antiviral activity |
Aug. 18, 2009 |
| 7556808 |
Dual inhibitors of HIV-1 gp-120 interactions |
Jul. 7, 2009 |
| 7541036 |
Human immunodeficiency virus type 1 (HIV-1) matrix (MA or p17) polypeptide capable of inducing anti-p17 antibodies that neutralize the proinflammatory activities of the MA protein |
Jun. 2, 2009 |
| 7537765 |
Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
May. 26, 2009 |
| 7531181 |
Gp120 specific antigens and uses thereof |
May. 12, 2009 |
| 7527925 |
Purified pol DNA, a recombinant DNA construct for expression of HIV pol polypeptide sequences and a cell containing such construct |
May. 5, 2009 |
| 7521426 |
HIV-specific CTL inducing peptides and medicaments for preventing or treating AIDS comprising the peptides |
Apr. 21, 2009 |
| 7510715 |
Protozoan derived compositions and methods of use thereof |
Mar. 31, 2009 |
| 7488481 |
Polypeptides derived from anti-HIV-1 gp120 antibodies that abrogate gp120 binding to CCR5 |
Feb. 10, 2009 |
| 7482016 |
Immunogenic compositions comprising HIV-1 acetylated Tat polypeptides |
Jan. 27, 2009 |
| 7476386 |
Mixed lipopeptide micelles for inducing an immune response |
Jan. 13, 2009 |
| 7442525 |
Method for expressing HIV polypeptides |
Oct. 28, 2008 |
| 7438914 |
Composition and method for enhancing immune response |
Oct. 21, 2008 |
| 7431928 |
Identification of new CD8 epitopes from HIV-1 proteins |
Oct. 7, 2008 |
| 7410801 |
Lambda phage display system and the process |
Aug. 12, 2008 |
| 7408053 |
Recombinant DNA constructs for GAG polypeptides and polypeptides produced thereby |
Aug. 5, 2008 |
| 7384734 |
Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors |
Jun. 10, 2008 |
| 7384637 |
Drug for AIDS treatment |
Jun. 10, 2008 |
| 7378490 |
Cyclic peptides and aids vaccines |
May. 27, 2008 |
| 7378515 |
Synthetic gagpol genes and their uses |
May. 27, 2008 |
| 7361459 |
Antiviral inhibition of capsid proteins |
Apr. 22, 2008 |
| 7351412 |
Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated-virus (LAV) and proteins encoded by said LAV genomic RNA |
Apr. 1, 2008 |
| 7348136 |
Method and device for detecting feline immunodeficiency virus |
Mar. 25, 2008 |
| 7335360 |
Method and device for detecting feline immunodeficiency virus |
Feb. 26, 2008 |
| 7335365 |
HIV-encoded chemoattractant |
Feb. 26, 2008 |
| 7318927 |
Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
Jan. 15, 2008 |
| 7311916 |
Methods of eliciting broadly neutralizing antibodies targeting HIV-1 gp41 |
Dec. 25, 2007 |
| 7306804 |
HIV-specific T-cell induction |
Dec. 11, 2007 |
| 7297784 |
DNA encoding T-1249 and other viral fusion inhibitor peptides useful for treating aids |
Nov. 20, 2007 |
| 7291337 |
Peptide having an affinity for gp120 |
Nov. 6, 2007 |
| 7291338 |
Method and device for detecting feline immunodeficiency virus |
Nov. 6, 2007 |
| 7285271 |
Antigenic composition comprising an HIV gag or env polypeptide |
Oct. 23, 2007 |
| 7285278 |
Method and device for detecting feline immunodeficiency virus |
Oct. 23, 2007 |
| 7285272 |
Method and device for detecting feline immunodeficiency virus |
Oct. 23, 2007 |
| 7276333 |
Viral infection inhibitor targeting integrase N-terminal domain |
Oct. 2, 2007 |
| 7276242 |
Vipox vector coding an HIV antigen and a cytokine |
Oct. 2, 2007 |
| 7273695 |
HIV immunoassays using synthetic envelope polypeptides |
Sep. 25, 2007 |
| 7273614 |
Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids |
Sep. 25, 2007 |
| 7262270 |
Fusion protein construct and method for inducing HIV-specific serum IgG and secretory IgA antibodies in-vivo |
Aug. 28, 2007 |
| 7255862 |
ALVAC/FIV constructs |
Aug. 14, 2007 |
| 7232685 |
Cell lines with latent immunodeficiency virus and methods of use thereof |
Jun. 19, 2007 |
| 7226598 |
Peptide inhibitors of HIV entry |
Jun. 5, 2007 |
|
|
|
